Jennifer Tucci
About Jennifer Tucci
Jennifer Tucci is a Sr. Site Monitor at Bristol-Myers Squibb with over 20 years of experience in the Biotech/Pharmaceutical Research Industry.
Company
Jennifer Tucci is currently employed at Bristol-Myers Squibb, where she holds the position of Senior Site Monitor. She has been with the company since October 2014, bringing her extensive background and expertise to their clinical research projects.
Title
Jennifer Tucci holds the title of Senior Site Monitor. In this role, she is responsible for overseeing the total site management, which includes site selection, site initiation, interim monitoring, and close-out visits. Her position requires keen attention to detail and strong organizational skills to ensure the smooth progression of clinical trials.
Education and Expertise
Jennifer Tucci has a diverse educational background. She earned an Associate of Science in Registered Nursing/Registered Nurse from The College of Saint Catherine. Additionally, she achieved an Associate of Arts in Marketing & Management from Hutchinson Area Technical Institute. Her education has provided a strong foundation for her over 20 years of experience in the Biotech/Pharmaceutical Research Industry. She specializes in monitoring Phase I through IV clinical trials and has expertise in therapeutic areas such as Oncology, Pulmonary, Cardiology, Nephrology, Gastroenterology, Gynecology, Hematology, Rheumatology, and Urology.
Background in Clinical Research
Before her current role at Bristol-Myers Squibb, Jennifer Tucci worked as a Senior Clinical Research Associate at Execupharm from 2011 to 2013. She has also held positions as a Senior CRA at Celgene from 2010 to 2011 and at Amgen from 2002 to 2010. Her extensive background underscores her capabilities in clinical research and site monitoring.
Professional Experience
Jennifer Tucci's professional journey in the Biotech/Pharmaceutical Research Industry spans over 20 years. Throughout her career, she has been responsible for total site management across multiple organizations, including Bristol-Myers Squibb, Execupharm, Celgene, and Amgen. Her expertise covers a range of therapeutic areas, and she has significant experience in monitoring clinical trials from Phase I through Phase IV.